argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
782.17
-5.14 (-0.65%)
At close: May 8, 2026, 4:00 PM EDT
790.00
+7.83 (1.00%)
After-hours: May 8, 2026, 7:41 PM EDT
argenx SE Employees
argenx SE had 1,863 employees as of December 31, 2025. The number of employees increased by 264 or 16.51% compared to the previous year.
Employees
1,863
Change (1Y)
264
Growth (1Y)
16.51%
Revenue / Employee
$2,545,609
Profits / Employee
$799,267
Market Cap
49.10B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,863 | 264 | 16.51% |
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 148 | 78.72% |
| Dec 31, 2019 | 188 | 83 | 79.05% |
| Dec 31, 2018 | 105 | 32 | 43.84% |
| Dec 31, 2017 | 73 | 15 | 25.86% |
| Dec 31, 2016 | 58 | 17 | 41.46% |
| Dec 31, 2015 | 41 | 9 | 28.13% |
| Dec 31, 2014 | 32 | 10 | 45.45% |
| Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Vertex Pharmaceuticals | 6,400 |
| Moderna | 4,700 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
ARGX News
- 1 day ago - Argenx: FDA approves label expansion for Vyvgart, Vvygart Hytrulo - TheFly
- 1 day ago - argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG - GlobeNewsWire
- 2 days ago - Argenx price target lowered to $1,170 from $1,230 at Morgan Stanley - TheFly
- 2 days ago - Argenx price target raised to $1,135 from $1,120 at Guggenheim - TheFly
- 2 days ago - Argenx price target raised to $1,260 from $1,247 at Wells Fargo - TheFly
- 3 days ago - Argenx price target lowered to $1,222 from $1,227 at Stifel - TheFly
- 4 days ago - argenx to Present at BofA Securities 2026 Health Care Conference - GlobeNewsWire
- 4 days ago - argenx Announces Results of Annual General Meeting and Board of Directors' Appointment of Karen Massey as Chief Executive Officer - GlobeNewsWire